Intercorrências pelas drogas utilizadas nos esquemas poliquimioterápicos em hanseníase
The authors present the clinical side effects produced by drugs used in multidrug therapy scheme standardized by World Health Organization for Leprosy disease. The study encompasses the experience in eight years with a total of 980 patientes, 496 (50%) of which were allocated in thepaucibacillary le...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 1995 |
| País: | Brasil |
| Institución: | Instituto Lauro de Souza Lima (ILSL) |
| Repositorio: | Hansenologia Internationalis (Online) |
| Idioma: | portugués |
| OAI Identifier: | oai:ojs.periodicos.saude.sp.gov.br:article/36487 |
| Acceso en línea: | https://periodicos.saude.sp.gov.br/hansenologia/article/view/36487 |
| Access Level: | acceso abierto |
| Palabra clave: | Poliquimioterapia em Hanseníase Intercorrências pelas drogas Multidrug therapy for leprosy Side effects |
| Sumario: | The authors present the clinical side effects produced by drugs used in multidrug therapy scheme standardized by World Health Organization for Leprosy disease. The study encompasses the experience in eight years with a total of 980 patientes, 496 (50%) of which were allocated in thepaucibacillary leprosy scheme and 484 (49.3%) in the multibacillary scheme. Side effects were observed which where attributed to the drugs that were used - Rifampicin, Dapsone and Clofazimine in 18 (1,8%) of the cases. Among the paucibacillary patients the side effects were observed in 10 (2%) and among the multibacillary patients in 8 (1.6%). In all the cases the standard scheme was adapted thus allowing a continuation of the treatment. |
|---|